HomeCompareNAV vs MRK

NAV vs MRK: Dividend Comparison 2026

NAV yields 541.87% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NAV wins by $114979.17M in total portfolio value
10 years
NAV
NAV
● Live price
541.87%
Share price
$44.50
Annual div
$241.13
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$114979.22M
Annual income
$84,355,398,966.77
Full NAV calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — NAV vs MRK

📍 NAV pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNAVMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NAV + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NAV pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NAV
Annual income on $10K today (after 15% tax)
$46,058.54/yr
After 10yr DRIP, annual income (after tax)
$71,702,089,121.75/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, NAV beats the other by $71,702,080,793.34/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NAV + MRK for your $10,000?

NAV: 50%MRK: 50%
100% MRK50/50100% NAV
Portfolio after 10yr
$57489.64M
Annual income
$42,177,704,382.46/yr
Blended yield
73.37%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

NAV
Analyst Ratings
8
Buy
19
Hold
5
Sell
Consensus: Hold
Price Target
$20.00
-55.1% upside vs current
Range: $20.00 — $20.00
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NAV buys
0
MRK buys
0
No recent congressional trades found for NAV or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNAVMRK
Forward yield541.87%2.76%
Annual dividend / share$241.13$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$114979.22M$56.8K
Annual income after 10y$84,355,398,966.77$9,798.13
Total dividends collected$112366.23M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy
Analyst price target$20.00$128.54

Year-by-year: NAV vs MRK ($10,000, DRIP)

YearNAV PortfolioNAV Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$64,887$54,186.52$11,206$366.19+$53.7KNAV
2$398,024$328,595.73$12,650$502.35+$385.4KNAV
3$2,309,679$1,883,793.41$14,407$694.19+$2.30MNAV
4$12,687,609$10,216,252.22$16,585$967.82+$12.67MNAV
5$66,024,585$52,448,843.61$19,342$1,363.89+$66.01MNAV
6$325,727,259$255,080,952.36$22,913$1,947.19+$325.70MNAV
7$1,524,623,898$1,176,095,730.75$27,662$2,823.89+$1524.60MNAV
8$6,776,135,933$5,144,788,362.32$34,159$4,173.35+$6776.10MNAV
9$28,620,396,614$21,369,931,165.66$43,337$6,308.80+$28620.35MNAV
10$114,979,223,344$84,355,398,966.77$56,776$9,798.13+$114979.17MNAV

NAV vs MRK: Complete Analysis 2026

NAVStock

Navistar International Corporation, through its subsidiaries, manufactures and sells commercial trucks, diesel engines, school and commercial buses, and service parts for trucks and diesel engines worldwide. The company operates through four segments: Truck, Parts, Global Operations, and Financial Services. It manufactures and distributes Class 4 through 8 trucks and buses in the common carrier, private carrier, government, leasing, construction, energy/petroleum, and student and commercial transportation markets under the International and IC brands; and designs, engineers, and produces sheet metal components, including truck cabs and engines. The company also provides customers with proprietary products needed to support the International commercial truck, IC bus, and engine lines, as well as other product lines; and a selection of other standard truck, trailer, and engine aftermarket parts. In addition, it manufactures and distributes mid-range diesel engines, as well as provides customers with additional engine offerings in the agriculture, marine, genset, and light truck markets; sells engines to original equipment manufacturers (OEM) for various on-and-off-road applications; and offers contract manufacturing services under the MWM brand to OEMs for the assembly of their engines. Further, the company provides retail, wholesale, and lease financing of products of its trucks and parts, as well as financing for wholesale and retail accounts receivable. Additionally, it offers military parts and chasis. The company markets its commercial products through an independent dealer network, as well as through retail outlets; and its reconditioned used trucks to owner-operators and fleet buyers through its network of used truck dealers. It operates approximately 1,052 outlets in the United States and Canada, and 89 outlets in Mexico. Navistar International Corporation was founded in 1902 and is headquartered in Lisle, Illinois.

Full NAV Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this NAV vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NAV vs SCHDNAV vs JEPINAV vs ONAV vs KONAV vs MAINNAV vs JNJNAV vs ABBVNAV vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.